The Technical Analyst
Select Language :

NuCana PLC [NCNA]
- Stock Price, Forecast, Insider, Ratings, Fundamentals & Signals

Exchange: Nasdaq Global Select ->Biotechnology

Last updated: 27 Oct 2021 @ 04:17 am

NuCana PLC is listed at the NASDAQ Exchange

-2.51% GBP2.33


FUNDAMENTALS
MarketCap: 121.54 mill
EPS: -1.143
P/E: 0.000
Earnings Date: Aug 19, 2021
SharesOutstanding: 52.16 mill
Avg Daily Volume: 1.879 mill
RATING 2021-10-25
B+
Buy
RATING DETAILS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Neutral
P/E: Sell
Price To Book: Strong Buy
QUARTER GROWTHS
1/202/203/204/201/212/21
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debt

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - GBP2.34
Forecast 2: 16:00 - GBP2.34
Forecast 3: 16:00 - GBP2.34
SCORE
-5.63
Sell
Score Algorithm Version: 0.9L
Last version updated: Wed 21th July 2021
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price GBP2.33 (-2.51% )
Volume 1.012 mill
Avg. Vol. 1.879 mill
% of Avg. Vol 53.85 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for NuCana PLC

Last 12 Months

Last 12 months chart data with high, low, open and close for NuCana PLC

RSI

Intraday RSI14 chart for NuCana PLC
The Live Chart for NuCana PLC
Profile picture for
            NuCana PLC

NCNA

NuCana PLC is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for cancer patients using its ProTide technology. Its pipeline includes Acelarin, NUC-3373 and NUC-7738. Acelarin is a nucleotide analog and is a ProTide transformation of gemcitabine for the treatment of cancer. Acelarin is designed to generate and maintain higher concentrations of the anti-cancer metabolite inside the tumor. NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil (5-FU). NUC-3373 is being developed for patients with advanced solid tumors. It is developing NUC-3373 as a therapy for colorectal cancer and other solid tumors. NUC-7738 is a ProTide of 3’-deoxyadenosine and is able to enter cells independently of nucleoside transporters. It is developing NUC-7738 for patients with either solid or hematological malignancies.

Last 10 Buy Signals
Date Signal @
BTCUSDOct 26 - 23:1360 612
DOGEUSDOct 26 - 23:08$0.258
XRPUSDOct 26 - 23:051.113
DOGEUSDOct 26 - 22:50$0.258
BTCUSDOct 26 - 22:3060 576
XRPUSDOct 26 - 21:571.116
BTCUSDOct 26 - 21:5460 607
DOGEUSDOct 26 - 21:12$0.258
BTCUSDOct 26 - 21:0760 705
XRPUSDOct 26 - 20:481.112

Stock Peers

Company Price Change
NCNA2.33-2.51%
ENLV8.58-2.17%
ERYP3.02-8.21%
IMV1.5700.64%
JAGX2.4822.77%
NOVN6.89-3.37%
OSMT1.820-0.55%
SVRA1.170-2.50%
TELA12.680.63%
TMDI1.700-0.58%
ZYNE3.76-2.34%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.